January 6th, 2015
Paris, France and Lausanne, Switzerland Voisin Consulting Life Sciences (VCLS), the global healthcare product development consultancy, and iQone Healthcare, a specialty pharmaceutical company focused on pharmaceutical distribution, sales, marketing and contract services in Europe, today announced a partnership to provide biotech and pharmaceutical companies with integrated commercialization services in Switzerland.
This partnership is the result of the experience integrating our regulatory, market access, medical, distribution, marketing and sales capabilities for a number of common clients over the last years said VCLS Founder and CEO Emmanuelle M. Voisin, Ph.D. It was our common clients who encouraged us to join forces in order to provide seamless services across many functions
This partnership enables VCLS and iQone Healthcare to jointly manage all activities related to marketing in Switzerland, from obtaining market approval and establishing price and reimbursement from Swiss Authorities, importing the product, building pharmacovigilance and medical information systems, through to raising awareness about the medicine and administering sales.
Most pharmaceutical companies are targeting Switzerland as part of the first set of countries for launching innovative medicines, alongside Europe and the United States said Laurent Massuyeau, iQone Healthcare President. The question is then: do I build the local capabilities required for marketing, from the management of the regulatory process, through to the creation of a fully functional sales, marketing and medical team? Our clients have led us to build a fully integrated, more cost-effective solution to manage these activities, while retaining ownership of the medicine
Having integrated the marketing process from start to finish, the partners offer flexible business models aligned with the long-term strategy of their clients in Europe.
About Voisin Consulting Life Sciences
Voisin Consulting Life Sciences is a global product development consultancy, which guides Biotechnology, Pharmaceutical and Medtech manufacturers throughout product development and commercialization. From discovery to patients, VCLS assists innovators to design product development strategies that optimize clinical development in order to drive commercial success, through an understanding of both regulators and payers.
VCLS team of health product specialists seamlessly supplements innovative life sciences companies’ resources with strategic advice and cross-functional operational capabilities. The firm offers integrated solutions to development planning, manufacturing, quality and controls, nonclinical and clinical testing, safety monitoring, and interactions with regulators and payers. With offices in Cambridge and San Francisco (MA & CA, USA), London (UK), Paris and Rennes (France), Lausanne (Switzerland), Bangalore (India), and Singapore, VCLS serves a broad range of developers and investors.
For more information, visit www.voisinconsulting.com
About iQone Healthcare
iQone Healthcare is a Swiss-based EU specialty pharmaceutical company and service provider focused on three main areas of expertise, oncology, immunology as well as bone & tissues disorders.
iQone Healthcare’s corporate focus is to provide U.S. and Asian pharma clients with innovative commercialization solutions in Europe for their specialty pharmaceuticals.
iQone Healthcare is headquartered in Switzerland, with operations in France, Germany, Italy, Switzerland and Spain, and a distributor network covering most EU markets. iQone Healthcare senior management is highly experienced in building European commercial operations for specialty pharmaceuticals.
For more information, visit www.iqone-healthcare.com
LaVoie Strategic Communications Group
David Connolly, +1-617-374-8800, ext. 108 – email@example.com